Old Web
English
Sign In
Acemap
>
authorDetail
>
Tennessee Oncology
Tennessee Oncology
Medicine
Internal medicine
Multicentric Castleman's disease
MEK inhibitor
Interleukin 6
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Providing uninterrupted oral oncolytic therapies during the COVID-19 pandemic.
2020
Journal of Clinical Oncology
Edward Arrowsmith
Rachel L Mitchell
Jack L. Taylor
Stephen Matthew Schleicher
Natalie R. Dickson
Stacey McCullough
Tennessee Oncology
Show All
Source
Cite
Save
Citations (0)
Exploiting interleukin 6 in multicentric Castleman's disease
2014
Charles Swanton
Tennessee Oncology
Show All
Source
Cite
Save
Citations (0)
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer Hope S. RugoAdam M. BrufskyMarianne Ulcickas Yood • Debu TripathyPeter A. KaufmanMusa Mayer • Bongin YooOyewale O. AbidoyeDenise A. Yardley
2013
Hope S. Rugo
Adam Brufsky
Marianne Ulcickas Yood
D. Tripathy
Peter A. Kaufman
Musa Mayer
Bongin Yoo
Oyewale O. Abidoye
Denise A. Yardley
Tennessee Oncology
Show All
Source
Cite
Save
Citations (0)
1